I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer
This study is to explore the markers in early prediction of the efficacy of pre-operative pertuzumab plus trastuzumab (PH) combined with chemotherapy for early stage or locally advanced human epidermal growth factor receptor-2 (HER-2) positive primary breast cancer.
HER2
immunohistochemistry
her1
pertuzumab + trastuzumab
cancer
- 0 views
- 19 Feb, 2024